Location History:
- Toronto, CA (US) (2014)
- Toronto, CA (1997 - 2020)
Company Filing History:
2 out of 26 
2 out of 2 
2 out of 497 
Years Active: 1997-2020
Title: **Jean Gariepy: Innovating Cancer Treatment from Toronto**
Introduction
Jean Gariepy is a notable inventor based in Toronto, Canada, whose work has led to significant advancements in the field of cancer research. With a total of three patents to his name, Gariepy focuses on the development of innovative therapeutic and diagnostic proteins that can potentially revolutionize cancer treatment.
Latest Patents
One of Gariepy's latest patents is titled "Cytotoxic heteromeric protein combinatorial libraries." This method involves constructing, identifying, and utilizing new therapeutic proteins that bind specifically to target cells. By mutating a binding subunit of a wild-type heteromeric cytotoxic protein, Gariepy has created a library of microorganism clones that produce mutant proteins screened for their ability to bind to and eliminate target cells effectively.
Another significant patent by Gariepy is the "Method for selectively purging CD77+ cells from bone marrow." This innovative technique allows for the selective purging of CD77 positive cells prior to autologous transplantation. The method utilizes shiga toxin or shiga-like toxin-1 to effectively kill or remove CD77 positive cells, offering promising treatment avenues for conditions such as non-Hodgkin's lymphomas.
Career Highlights
Throughout his career, Jean Gariepy has worked with prominent institutions such as the Ontario Cancer Institute and Molecular Templates, Inc. His contributions in these esteemed organizations have allowed him to leverage his expertise and explore innovative solutions for complex medical challenges.
Collaborations
Gariepy has collaborated with noteworthy professionals in the field, including Mark Robert Bray and Aws Abdul-Wahid. These partnerships have enabled him to enhance his research and broaden the impact of his inventions in the medical community.
Conclusion
Jean Gariepy's inventive spirit and groundbreaking patents make him a significant figure in the realm of cancer research. His work not only reflects a commitment to innovation but also offers hope for better treatment modalities in the fight against cancer. With a record of tangible advancements, Gariepy continues to inspire future inventors in the medical field.